FUS Ablation Feasible for Intermediate-Risk Prostate Cancer
WEDNESDAY, Feb. 10, 2021 -- Targeted focal therapy with magnetic resonance imaging (MRI)-guided focused ultrasound ablation is feasible for the treatment of intermediate-risk prostate cancer, according to a study published online Feb. 2 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | MRI Scan | Pharmaceuticals | Prostate Cancer | Study | Ultrasound